Astrazeneca plc - ADR

NASDAQ:AZN  
66.64
+1.99 (+3.08%)
4:05:01 PM EDT: $66.64 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)212.88B
Current PEN/A
Forward PE 20.13
2yr Forward PE 17.54
See more stats
Estimates Current Quarter
Revenue$10.73 Billion
Adjusted EPS$0.77
See more estimates
10-Day MA$65.57
50-Day MA$64.79
200-Day MA$61.41
See more pivots

Astrazeneca plc - ADR Stock, NASDAQ:AZN

Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, Cambridgeshire CB2 0AA
Phone: +44.20.3749.5000
Number of Employees: 83100

Description

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. It focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. These pharmaceutical products are then manufactured, marketed and sold. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.